|
|
|
|
NUCLEODUR® C18 Pyramid
|
|
high purity silica phase for HPLC
|
octadecyl modification with polar endcapping
suitable for aqueous eluents · endcapped · 14 % C · USP L1
|
|
Features
|
|
pore size 110 Å, available particle sizes 1.8 µm, 3 µm and 5 µm
7 and 10 μm particles for preparative purposes are available on request
interesting polar selectivity features
excellent base deactivation; suitable for LC/MS due to low bleeding characteristics
pH stability 1 – 9
separation mechanism based on polar interactions and hydrophobic (van der Waals) interactions
|

|
 |
classes of compounds separated so far: analgesics, penicillin antibiotics, nucleic acid bases, water-soluble vitamins, complexing agents, organic acids
|
Standard programme* of columns packed with NUCLEODUR® C18 Pyramid
|
|
|
|
 |